Latest Market News

Imricor Medical Systems has secured Virginia Commonwealth University Health as the third US site for its VISABL-AFL clinical trial, advancing its FDA approval pathway for MRI-guided cardiac ablation technology.

Paladin Energy reports a strong production ramp-up at its Langer Heinrich Mine and confirms robust progress on the Patterson Lake South project, supported by a strengthened balance sheet and a positive uranium market outlook.

Charter Hall Long WALE REIT has updated its dividend distribution details for Q4 2025, confirming an ordinary unfranked dividend and adjusting the Dividend Reinvestment Plan price to reflect a modest discount.

Praemium Limited reported a 14% year-on-year increase in total Funds Under Administration to $70.5 billion for Q2 FY26, completing the OneVue transition and seeing strong net inflows in its Spectrum and Powerwrap platforms.

Jindalee Lithium has reported robust assay results from its 2025 core drilling program at the McDermitt Lithium Project, highlighting significant near-surface lithium and magnesium mineralisation. These findings support ongoing metallurgical testwork and feasibility studies aimed at optimising project economics.

Australian Strategic Materials and Energy Fuels are set to discuss their proposed acquisition in a joint webcast, offering investors a closer look at this strategic move.

Pengana International Equities has raised its fully franked quarterly dividend to 1.4 cents per share, reflecting confidence in its earnings. Meanwhile, the company’s Independent Board Committee continues to evaluate strategic options, promising an update by February’s end.

Paladin Energy reports a 16% rise in uranium production at Langer Heinrich Mine, with strong sales and a fortified balance sheet positioning the company for growth. Exploration advances in Canada and leadership changes signal a strategic push forward.

Sovereign Metals has recovered a heavy rare earth monazite concentrate from its Kasiya project tailings, revealing concentrations of critical elements that surpass those of the world’s largest producers. This discovery could add a lucrative by-product stream at minimal cost, enhancing Kasiya’s strategic value amid tightening global supply chains.

OMG Group Limited has reported its first positive operating cashflow quarter, driven by a 63% year-on-year sales increase and expansion into premium Japanese matcha wholesale. This milestone signals a turning point in the company’s growth trajectory.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.